Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T22:50:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:36.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding warning that information may not be up to date was removed from the page. Core study details, contacts, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:22.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The two screenshots depict the same study detail page with only minor visual and layout differences; no substantive updates to the study data (eligibility, enrollment, or outcomes) were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:30:34.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:47:58.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Update to revision from v3.0.2 to v3.1.0 and addition of contact details for Sabine Zoechbauer-Mueller (sabine.zoechbauer-mueller@meduniwien.ac.at) with a phone-like number; effectively a version upgrade plus new contact information.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:32.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.